Patents Assigned to ONCOLOGIE, INC.
  • METHODS FOR TREATING CANCER WITH BAVITUXIMAB BASED ON LEVELS OF BETA2-GLYCOPROTEIN 1, AND ASSAYS THEREFOR
    Publication number: 20210032340
    Abstract: Disclosed are surprising new methods and kits for identifying and treating patients treatable with PS-targeting antibodies, particularly for identifying and treating cancer patients using bavituximab and bavituximab combination therapies. The methods and kits are based on the surprising finding that defined ranges of pre-treatment blood concentrations of ?2-glycoprotein 1 (?2GPI), particularly functional ?2GPI, act as an indicator to accurately predict patients with better treatment outcomes.
    Type: Application
    Filed: September 26, 2017
    Publication date: February 4, 2021
    Applicant: ONCOLOGIE, INC.
    Inventors: Min Tang, Joseph S. Shan, Steven W. King, Connie Chang, Michael A. Brown